Thomas Joeseph  Carrico net worth and biography

Thomas Carrico Biography and Net Worth

Insider of NeurAxis

Dr. Carrico is the Chief Regulatory Officer of NeurAxis, Inc. He has over 40 years of experience in the healthcare field, including 30 years prior to coming on board at NeurAxis in 2012, and has been involved in the study and application of techniques and treatments that directly affect the autonomic nervous system, especially regarding homeostasis and balance of the parasympathetic and the sympathetic nervous system. Dr. Carrico has a history of working with attorneys on state and national boards, which has positioned him to integrate into regulatory responsibilities at NeurAxis. Dr. Carrico received his undergraduate education from Indiana University and his Doctorate from Palmer College of Chiropractic.

What is Thomas Joeseph Carrico's net worth?

The estimated net worth of Thomas Joeseph Carrico is at least $2.56 million as of April 1st, 2026. Carrico owns 331,903 shares of NeurAxis stock worth more than $2,555,653 as of September 17th. This net worth estimate does not reflect any other investments that Carrico may own. Learn More about Thomas Joeseph Carrico's net worth.

How do I contact Thomas Joeseph Carrico?

The corporate mailing address for Carrico and other NeurAxis executives is 11611 N. Meridian ST, Suite 330, Carmel, IN, 46032. NeurAxis can also be reached via phone at (812) 689-0791 and via email at [email protected]. Learn More on Thomas Joeseph Carrico's contact information.

Has Thomas Joeseph Carrico been buying or selling shares of NeurAxis?

Thomas Joeseph Carrico has not been actively trading shares of NeurAxis in the last ninety days. Most recently, on Wednesday, April 1st, Thomas Joeseph Carrico bought 667 shares of NeurAxis stock. The stock was acquired at an average cost of $1.96 per share, with a total value of $1,307.32. Following the completion of the transaction, the insider now directly owns 331,903 shares of the company's stock, valued at $650,529.88. Learn More on Thomas Joeseph Carrico's trading history.

Who are NeurAxis' active insiders?

NeurAxis' insider roster includes Gil Aharon (Director), Brian Carrico (CEO), and Thomas Carrico (Insider). Learn More on NeurAxis' active insiders.

Are insiders buying or selling shares of NeurAxis?

During the last twelve months, NeurAxis insiders bought shares 4 times. They purchased a total of 302,458 shares worth more than $1,039,192.96. The most recent insider tranaction occured on April, 1st when CFO Timothy Robert Henrichs bought 7,593 shares worth more than $14,882.28. Insiders at NeurAxis own 21.1% of the company. Learn More about insider trades at NeurAxis.

Information on this page was last updated on 4/1/2026.

Thomas Joeseph Carrico Insider Trading History at NeurAxis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2026Buy667$1.96$1,307.32331,903View SEC Filing Icon  
See Full Table

Thomas Joeseph Carrico Buying and Selling Activity at NeurAxis

This chart shows Thomas Joeseph Carrico's buying and selling at NeurAxis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeurAxis Company Overview

NeurAxis logo
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Read More

Today's Range

Now: $7.80
Low: $7.25
High: $8.06

50 Day Range

MA: $6.41
Low: $5.69
High: $7.21

2 Week Range

Now: $7.80
Low: $2.21
High: $9.33

Volume

398,955 shs

Average Volume

135,357 shs

Market Capitalization

$97.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47